```

FOR INSTITUTIONS

What Happens After Discharge?

Treatment saves lives.

The question is what happens next.

Recovery does not end when treatment ends. Yet for many organizations, the period after discharge remains largely invisible, difficult to verify, and disconnected from any structured continuity infrastructure.

The result is not necessarily clinical failure.

The result is continuity exposure.

```

THE SHIFT

The Risk Does Not End When Treatment Ends.
It Changes Hands.

Once a client leaves treatment, recovery unfolds in the environment where life actually happens — work, family systems, housing, relationships, community, and daily stress.

This is where long-term outcomes are ultimately decided.

And yet for much of the field, continuity beyond discharge remains largely voluntary, fragmented, and difficult to verify.

Treatment addresses the episode.
Recovery is decided across time.

EXPOSURE

Invisibility Is Not Neutral.
It Is Exposure.

What cannot be seen cannot be measured.
What cannot be measured cannot be defended.
And what cannot be defended becomes liability.

Financial. Operational. Reputational.

Employers & EAPs

Return-to-work is not resolution.

Union Health & Welfare Funds

Fiduciary duty extends beyond negotiation.

Family Offices

Capital deployed without continuity will not create stability.

Treatment Centers

Outcomes are decided after discharge.

×

FOR EMPLOYERS AND EMPLOYEE ASSISTANCE PROGRAMS

You Funded the Benefit. Do You Know What It Produced?

Employers and EAPs occupy a specific and consequential position in the treatment referral chain.

You assess.
You authorize.
You refer.
You reinstate.

And then the file closes.

What happens after discharge — the period when recovery is most fragile and risk is highest — is invisible to the institutions that funded and directed the treatment episode.

That invisibility is not neutral.

It is liability.

When an employee returns to work under a return-to-work agreement and something goes wrong in month seven — relapse, safety incident, termination — the question that follows is precise:

What did your institution know about what the treatment produced?

If the answer is nothing — that is not a defense.

It is the documentation of negligence.

What Employers Are Absorbing Without Knowing It

Substance use disorders cost employers an estimated $93 billion annually in lost productivity alone.

The majority of that cost is concentrated in the period after treatment — when the employee has returned to the workplace and the treatment center has closed the file.

Employers are funding a system that hands them the risk at the moment of discharge and provides no tools to manage it.

What EAPs Are Not Measuring

EAPs measure utilization.
They do not measure outcomes.

An EAP that refers a member to treatment without six-month outcome data has not completed due diligence.

It has completed a transaction.

The Question That Is Coming

Value-based care, behavioral health parity enforcement, and an evolving litigation landscape are converging on the same standard:

Referral is not the deliverable.
Outcome accountability is.

The institutions that begin building visibility into post-discharge outcomes now — before the regulatory environment requires it, before a bad outcome makes it a legal question — will be able to answer when asked.

The institutions that wait will not be waiting for a better time.

They will be waiting for worse outcomes.

The Mechanism

The Institutional Continuity Assessment™ is the formal process through which employers and EAPs establish visibility into the post-discharge outcome infrastructure of their treatment provider relationships.

It is not a consulting engagement.

It is a structural determination.

×

FOR UNION HEALTH AND WELFARE FUNDS

You Negotiated the Benefit.
Do You Know If It Works?

The Declaration (Start Here) +

When a union negotiates an addiction treatment benefit into a collective bargaining agreement, it is not a passive act.

It is a declaration that the benefit works.

That declaration carries obligations — fiduciary, representational, and political — that most union funds have not fully examined in the context of addiction treatment.

The Fiduciary Obligation +

Union health and welfare funds — particularly Taft-Hartley funds — carry explicit fiduciary obligations to their beneficiaries.

Trustees are required to act in the interest of fund participants.

That standard applies to how the fund's assets are deployed — including the treatment benefits those assets fund.

A fiduciary who cannot demonstrate that the benefit they negotiated produces measurable outcomes has a governance gap that is difficult to defend.

Regulators and plaintiffs' attorneys have consistently followed the money into areas where institutional actors were making consequential decisions without adequate accountability structures:

Pharmacy benefit management
Mental health parity compliance
Network adequacy standards

Addiction treatment is the next area.

The Representational Obligation +

Unions have a duty of fair representation.

When a member uses the addiction treatment benefit the union negotiated, receives treatment, returns to work, and subsequently relapses — the union's posture in any resulting grievance, arbitration, or termination proceeding is shaped by what it knows about the quality and continuity of the treatment that member received.

If the union knows nothing — because no one tracked outcomes — its ability to advocate effectively is compromised.

It cannot argue that the treatment failed if it has no evidence.
It cannot challenge a termination without post-discharge data.
It cannot make a credible argument for a second treatment opportunity without understanding why the first did not hold.

The Political Obligation +

A union membership that watches a brother or sister go through treatment, return to work, relapse, and lose their job — and then asks what the union did to ensure the treatment actually worked — is a membership with a legitimate grievance.

Not a formal one.

An ethical one.

The addiction treatment benefit deserves the same scrutiny the pension fund gets.
The same oversight pharmacy benefits receive.
The same accountability standard applied everywhere else.

The Mechanism +

The Institutional Continuity Assessment™ is the formal process through which union funds and trustees establish documented evidence that the treatment benefit they negotiated produces measurable, longitudinal outcomes.

It is the governance record that demonstrates fiduciary responsibility — not just at negotiation, but in ongoing oversight.

Because in the absence of evidence, the system does not default to trust.

It defaults to scrutiny.

×

FOR FAMILY OFFICES & PRIVATE CLIENT ADVISORS

You Protect Generational Wealth.
Trauma Transfers Too.

Family offices manage capital across generations.
Substance use disorder moves the same way.

THE ENGAGEMENT

When a principal, a beneficiary, or a key executive enters treatment, your office does what it is designed to do:

You fund the placement. You coordinate the logistics. You ensure access to the best available care.

And when the episode ends, you receive a discharge summary.

Operationally, the engagement is complete.

THE GAP

But recovery does not end at discharge.

That is where outcomes are decided.

What happens next — whether stability holds or collapses — sits outside the system you oversee.

No reporting. No verification. No continuity of accountability.

The phase that determines whether the intervention worked is structurally invisible.

THE CONSEQUENCE

That invisibility is not benign.

It is where recurrence begins.

Repeated placements.
Interventions escalate.
Trust erodes across the family system — quietly, then all at once.

Not because the resources were insufficient.

But because the system stopped tracking the outcome at the point it mattered most.

THE EXPOSURE

The financial exposure has a number.

The reputational exposure does not — until the moment it does.

And at that moment, the number is no longer the primary problem.

THE ESCALATION

A principal in active recurrence does not remain contained.

It surfaces.
In boardrooms.
In succession conversations.
In the room where control of the next generation is being determined.

At that point, this is no longer a private matter.

It is a governance issue.

THE DECISION WINDOW

Because the estate does not wait for recovery.

Capital continues to move.
Decisions continue to be made.
Authority continues to shift — whether stability is present or not.

If instability is present in that moment, it does not stay isolated.

It enters the system that allocates capital.

It influences judgment.

It alters decisions that cannot be reversed.

By the time it is visible, it is no longer a clinical problem.

It is a structural one — and it is already governing decisions.

THE STANDARD

Funding care is not the deliverable.

Sustained stability is.

THE MECHANISM

The Institutional Continuity Assessment™ does not advise.

It determines whether the treatment relationships your office funds are structurally capable of producing sustained recovery — or whether they are designed, however unintentionally, to return your family to the same point of instability.

Because if continuity is your mandate — what happens after discharge is not optional oversight.

It is part of your responsibility.

And right now, it is:
Unmeasured.
Unverified.
Unaccounted For.

Which means one of two things is true:

Either the outcomes are being produced — and no one is confirming them.

Or they are not — and the system continues to fund the same point of failure.

In either case, the risk is already inside the structure.

The question is not whether to evaluate it.

It is whether you will determine it — or continue to operate without seeing it.

×

FOR TREATMENT CENTERS

The Organizations That Define
What Comes Next
Are Already Building It.

The Model

Most treatment systems were designed to stabilize.

That was the standard.

The standard has shifted.

Episodic outcomes limit what your organization can prove, sustain, and scale.

What happens after clients leave is rarely visible to the organization that provided care.

Which means results are not verified —
they are assumed.

The Question

Before anything else — one question determines everything:

What happens to your clients when the episode ends?

Why Longitudinal Design Matters

Most treatment systems are organized around episodes of care:

Detox → Residential → PHP → IOP → Discharge

But recovery does not conform to episodic timelines.

The American Society of Addiction Medicine's 4th Edition did not simply refine placement criteria.

It formally identified the dimensional realities that continue after discharge — and exposed how little infrastructure exists to sustain them.

The organizations that will define the next era of behavioral health will not be those that stabilize fastest —
but those that sustain recovery longest.

Longitudinal design is not simply a clinical refinement.

It is a structural shift.

Systems designed for longitudinal stability outperform episodic models by increasing long-term recovery capital, strengthening outcome resilience, and reinforcing institutional confidence in performance across time.

What This Enables

Centers that extend structured continuity beyond discharge gain the ability to:

Demonstrate measurable long-term outcomes
Build alumni infrastructure that functions as accountability
Strengthen referral confidence through sustained results
Establish credibility rooted in structured follow-through
Invest meaningfully in extended recovery support
Show readiness for value-based reimbursement models

Continuity is not a safeguard.
It is infrastructure.

When growth is built on sustained recovery rather than episodic completion, it becomes structurally aligned with outcome reality.

The Mechanism

The Institutional Continuity Assessment™ evaluates whether a verifiable continuity architecture exists beyond discharge and how effectively clients connect to it..

It is not a consulting engagement.

It is a structural determination.

The exposure is documented.

The question is whether your organization is the one that addressed it — or the one that didn't.